Organon & Co. (OGN)

Every figure this model derived for OGN, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 170,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,132,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 5,111,000,000 AssetsCurrent 2026-06-30
current liabilities 2,616,000,000 LiabilitiesCurrent 2026-06-30
equity 1,006,000,000 StockholdersEquity 2026-06-30
interest expense 468,000,000 InterestExpense 2026-06-30
ocf 737,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 6,127,000,000 Revenues 2026-06-30
sbc 75,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up OGN on one particular measure came for.

RatioValue
current ratio1.95
current ratio reported1.95
dilution pct0.62
fcf margin9.25
owner earnings margin8.03
revenue growth-2.45
revenue growth per share-3.06
sbc pct revenue1.22

What to be careful about

What this model itself distrusts about OGN's figures. Written by the derivation as it ran, not added afterwards.